During the past decade, Epilepsiezentrum Kork conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Epilepsiezentrum Kork" #1 sponsor was "SK Life Science, Inc." with 2 trials, followed by "Bial - Portela C S.A." with 1 trials sponsored, "Cyberonics, Inc." with 1 trials sponsored, "Eisai GmbH" with 1 trials sponsored and "Eisai Limited" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Epilepsiezentrum Kork" are "Epilepsy" (4 trials), "Partial Epilepsy" (3 trials), "Focal Onset Seizures" (1 trials) and "Photosensitive Epilepsy" (1 trials). Many other conditions were trialed in "Epilepsiezentrum Kork" in a lesser frequency.

Most popular intervention types in "Epilepsiezentrum Kork" are "Drug" (8 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "YKP3089" (2 trials), "Zonegran" (2 trials), "ACT-709478 for oral use" (1 trials) and "Best Medical Practive" (1 trials). Other intervention names were less common.

The vast majority of trials in "Epilepsiezentrum Kork" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Epilepsiezentrum Kork". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Epilepsiezentrum Kork, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Epilepsiezentrum Kork, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".